Category Archives: Neuroscience

McDermott to head Division of Neuroscience | HWCOM News – FIU News

Dr. Michael McDermott, an internationally renowned neurosurgeon, has been named chief of the Division of Neuroscience at the Herbert Wertheim College of Medicine. In this role, he will oversee and lead all curricular and clinical activities of the Division.

McDermott is widely known for advancing neurosurgical techniques and pioneering the surgical management of meningioma, a slow-growing tumor that affects the brain. He is an expert in the treatment of a wide variety of neurological disorders including skull base tumors, brain metastases, gliomas, hydrocephalus, central nervous system infections and complex tumors of the skull base and spinal cord.

He also serves as chief medical executive of Miami Neuroscience Institute at Baptist Health.

Read the original post:
McDermott to head Division of Neuroscience | HWCOM News - FIU News

The Neuroscience Market to rest on innovations in the next decade NeighborWebSJ – NeighborWebSJ

Market Report Summary

For Full Information ->Click Here

Read Full Press Release Below

With healthy CAGR of 6.4%, theglobalneuroscience marketis likely to grow from US$ 301.6 Mn in 2016 to US$ 520.8 Mn by 2025 end. This growth is mainly fuelled by advancement in neuroimaging and increasing R & D in neuroinformatics. Neuroscience Market: Global Industry Analysis (2012-2016)and Forecast (2017-2025),is the new publication of Persistence Market Research that focuses on merger and acquisition, strategic collaborations and technology, and technology transfer agreements, which play a vital role in the global neuroscience market.

Get Sample Copy of Report @https://www.persistencemarketresearch.com/samples/13390

Company Profiles

North America and Europe are expected to dominate the global neuroscience market in the assessed period of 8-years that is between 2017 and 2025.

Global Neuroscience Market: Relevance and Impact of Factors

Get To Know Methodology of Report @https://www.persistencemarketresearch.com/methodology/13390

Global Neuroscience Market: Forecast by Component Type

On the basis of component type, the global neuroscience market is segmented into instrument, software and services. Instrument segmented is sub-segmented into MRI imaging systems and neuromicroscopy, while services segmented divided into consulting services, installation services and maintenance services.

Instrument segment dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Instrument segment is the most attractive segment, with attractiveness index of 2.6 over the forecast period.

Instrument segment was valued atUS$ 221.6 Mnin 2016 and is projected to be valued atUS$ 408.1 Mn in 2025growing at aCAGR of 7.2%during the forecast period. This segment is expected to accounts for high revenue contribution to the global neuroscience market as compared to software and services segments over the forecast period.

Software segment is expected to be the second most lucrative segment in the global neuroscience market, with attractiveness index of0.3 duringthe forecast period. This segment was accounted for 15.4% value share in 2017 which is expected to drop down to 12.9 % revenue share in 2025.

Global Neuroscience Market: Forecast by End User

On the basis of end user, global neuroscience market is segmented into hospitals, diagnostic laboratories, research institutes, and academic institutes.

Diagnostics laboratory segment is expected to be the second most lucrative segment in the global neuroscience market by 2025 end. However, in terms of CAGR and revenue share, hospitals segment is expected to lead he market throughout the estimated period. In 2025, hospital segment is likely to grab 40.2% market share in 2025, expanding at a robustCAGR of 7.3%during the estimated period.

Research institutes segment is expected to be the least attractive segment in the global neuroscience market, with attractiveness index of 0.7 during the forecast period.

Access Full Report @https://www.persistencemarketresearch.com/checkout/13390

Global Neuroscience Market: Forecast by Region

On the basis of region, global neuroscience market is segmented into North America, Latin America, Europe, APAC and MEA. North America dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.

North America is projected to be the most attractive market with attractiveness index of 2.3 during the forecast period. Europe is expected to be the second most lucrative market, with attractiveness index of 1.1 respectively during the forecast period.

Europe Neuroscience market accounted for 23.9% share in 2017 and is projected to account for 23.1% share by 2025 end.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Website https://www.persistencemarketresearch.com

https://neighborwebsj.com/

Here is the original post:
The Neuroscience Market to rest on innovations in the next decade NeighborWebSJ - NeighborWebSJ

These Chattanooga area business people are on the move – Chattanooga Times Free Press

Contributed photography / Whitney Snardon

Whitney Evans Snardon joins Parkridge Health System as market associate administrator and co-ethics and compliance officer. In her role, Snardon works closely with Tom Ozburn, president and CEO of Parkridge Health, and facility leadership to catalyze growth projects throughout the system. She will support the growing neuroscience program at Parkridge Health, oversee housekeeping services and assist with operations at Parkridge Valley Child & Adolescent and Adult & Senior campuses. Snardon earned a Bachelor of Science degree from Loyola University, in New Orleans, and a Master of Health Administration degree from Tulane University School of Public Health and Tropical Medicine. She has served in several healthcare leadership roles, most recently as director of the neuroscience service line at Mercy Health Lourdes Hospital in Paducah, Kentucky. Under her leadership, the neuroscience program at Mercy Health Lourdes Hospital experienced significant service line growth and efficiency gains. Prior to that, Snardon served as administrative fellow for Bon Secours Mercy Health.

Ian Shives is named the executive director for Morning Pointe of Collegedale at Greenbriar Cove. Shives brings nearly a decade of senior living experience and proven leadership skills to the Morning Pointe of Greenbriar Cove team. Shives obtained his bachelor's degree in social work from Southern Adventist University in 2010, and served as the director of social services for Life Care Centers of America and the director of operations for Heritage Healthcare Management Services.

Adria Sherrill, FNP-C, joins CHI Memorial Center for Healthy Aging. Sherrill earned a bachelor's in nursing and a master's in nursing, family nurse practitioner, from the University of Tennessee at Chattanooga. She is an advanced registered nurse practitioner and certified in family medicine by the American Academy of Nurse Practitioners. Sherrill joins Alycia Cleinman, MD, geriatric medicine specialist, Cassie Rodriguez, MSN, NP-C, and Einre Lopez, LCSW, at CHI Memorial Center for Healthy Aging. The practice focuses on adults aging into geriatrics and providing quality health care that helps individuals remain healthy and active throughout their lives.

Jason Gibson, a 26-year veteran of the senior living field, promotes to vice president of operations for Legacy Senior Living, expanding the scope of his role to oversee the organization's family of 14 senior living communities across the Southeast. Gibson, who joined Legacy Senior Living as an operations specialist and most recently served as regional director of operations, has a long-standing record of carrying out Legacy Senior Living's mission to serve seniors with honor, respect, faith and integrity. After graduating from the University of Tennessee at Chattanooga with a degree in human services management, Gibson honed his experience at senior living communities throughout the Southeast before returning to his native Cleveland and joining the Legacy Senior Living team in January of 2019.

John Bottley, legal counsel for legal and risk services at Life Care Centers of America, promotes to vice president of legal and risk services for the Cleveland, Tennessee-based nursing home and senior living company. Bottley oversees and coordinates all litigation, regulatory matters, contracts and other general legal matters for Life Care. He also advises executive leadership on various issues. Bottley joined Life Care Legal and Risk Services in 2013 as legal counsel. Prior to that appointment, he clerked for state judges in Hamilton County. A native of Lawrenceville, Georgia, Bottley is a member of the Tennessee Bar Association, the Health Care Compliance Association and the Association of Corporate Counsel. He is licensed to practice law in both Tennessee and Georgia.

Linda Shriver-Buckner is named executive director of independent living community at the East Ridge Residence on Mack Smith Road. Shriver-Buckener has a diverse background in marketing, operations, and sales across several different industries such as state government, non-profits, and senior living. She previously served as a sales specialist for BrightSpace Senior Living for the past two years after serving as community relations director at the East Ridge Center. Shriver-Buckner also worked as a sales director at Hickory Valley Retirement Center. She is a 1986 graduate of Southern Adventist University and returned to Chattanooga in 2005.

Ashley Guthrie, FNP, joins The Austin Hatcher Foundation as clinical liaison. Guthrie is a family nurse practitioner and holds her M.S. Nursing from Belmont University. She has worked as a nurse and nurse practitioner in hospital, private care, and nonprofit settings. In her role as clinical liaison, she will be responsible for working alongside the clinical team at the foundation and pediatric health care providers to ensure all patients and their families utilize the support the foundation offers. Guthrie has been a longtime volunteer and board member, and she is the mother of a pediatric cancer survivor.

Holly Bischoff joins EMJ Construction as chief financial officer, responsible for the overall fiscal functions of EMJ and its subsidiaries and related companies. She continues to work with the executive leadership team to establish long range goals, strategies, plans and policies for each while aligning them with the overall mission, strategy and vision of EMJ. After graduating from Tennessee Technological University with a bachelor's in accounting, she attended the University of Oregon and earned an MBA with a concentration in finance. She began her career as a senior auditor at Arthur Andersen before moving to Brach's Confections where she served as a financial reporting supervisor and budgeting and planning manager. Bischoff joined EMJ in 2004 where she has served in successive positions, including controller, vice president of finance and accounting, senior vice president of finance and accounting and interim chief financial officer.

Darren Strickland is named as senior mortgage officer for First Horizon Bank. He serves the areas of Chattanooga and Cleveland, Tennessee, and North Georgia. Strickland is a certified mortgage loan officer and a member of the Chattanooga Mortgage Bankers Association. Strickland graduated from the University of West Georgia with a bachelor's degree in finance and business administration. Darren is a former president of the Chattanooga Mortgage Bankers Association and a past recipient of the Chattanooga Mortgage Banker of the Year award.

Tyler Clemmons joins The Austin Hatcher Foundation for Pediatric Cancer as as a licensed clinical social worker. Clemmons is a licensed clinical social worker and holds a M.S. in Social Work from The University of Alabama. He has provided mental health therapy to children and families in the Chattanooga area for the past four years. In his role with the foundation, he will continue to offer counseling, support, and case management through evidence-based treatments.

Read more:
These Chattanooga area business people are on the move - Chattanooga Times Free Press

OnlyFans Model And Neuroscience Student Is Giving Back To The Troops – BroBible

Cami Strella gives back to the troops in her own incredible way. The Instagram model utilizes her OnlyFans account to provide much-needed support to military members who are struggling.

The 27-year-old OnlyFans star is the daughter of immigrant parents, including one who is a veteran. Thats part of the reason that Cami has a special appreciation of the military. Her first viral post was a somber TikTok video posted on Veterans Day where she explains the tragic story of her Army officer friend who committed suicide after surviving a traumatic brain injury following three military deployments.

The suicide was what compelled Strella to go to school for neurological rehabilitation, so she could help other troops who were suicidal. She is attending graduate school where she is studying traumatic brain injuries (TBI) and spinal cord injuries (SCI) to hopefully save more lives.

To pay for her graduate school, Cami worked at strip clubs and in the adult industry. But following the COVID-19 lockdowns, shes now working for herself on OnlyFans. And she is succeeding, where she is in the top .3% of entertainers.

RELATED: Christian OnlyFans Model Says God Wont Judge Her For Risqu Job That Pays Her Seven Figures

I worked in a gentlemens club previously, and I became increasingly worried about paying for my graduate school tuition as my program started in May 2020, so I joined the site as a creator, Cami told Military Times.

Cami is also giving back to the troops on her OnlyFans.

If anything, I just want service members to know that I care, and that although it may be in an unusual way, Im fighting to help them, Strella said. I also donate 10 percent of my monthly earnings to a military charity and I typically have subscribers vote for which one they want me to donate to.

Cami said a lot of my more public content is geared towards the military community. I was raised in an area with a large concentration of service members of all branches, as well as federal government and contract workers, so I always felt embedded with the culture from a young age, Cami explained.

RELATED: Former Special Ed Teacher Strikes It Rich Becoming OnlyFans Star

When asked about how much she makes from OnlyFans, Cami reveals that it wasnt always easy.

I started in February 2020 and made $11.18, she said. Now, I rank in the top 0.88 percent of all creators worldwide.

She dispels the myth that everyone makes money on OnlyFans.

People seem to think that you just create an account and you instantly make money, and thats not how it works at all, she said. If you truly want to be successful with OnlyFans, you need to be ready to invest a significant amount of time, money, and energy, just like any business.

Cami points out, OnlyFans, unlike other social media platforms, does not have a built-in algorithm where others who dont know about you can find you. Its a direct-to-consumer type of model in which a creator has to do all of their own marketing outside of the platform.

Strella says she tries to make a name for herself by giving her fans a personal and intimate experience.

I truly love talking to my subscribers, she said. I have a few that I exchange letters with and it brings such a human touch in the digital age. Its helped me, too, to stay and feel connected during the pandemic.

You can read the entire interview with Cami over at Military Times.

RELATED: Bernard Tomics Girlfriend Gets Death Threats After OnlyFans Star Complained Of Conditions In Quarantine

Read the rest here:
OnlyFans Model And Neuroscience Student Is Giving Back To The Troops - BroBible

Cognition Therapeutics Publishes Evidence Identifying Receptor Integral in Parkinson’s Disease Pathology – GlobeNewswire

PITTSBURGH, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage response pathways, today announced that a peer-reviewed manuscript, entitled, Sigma-2-Receptor Antagonists Rescue Neuronal Dysfunction Induced by Parkinsons Patient Brain-Derived -Synuclein, has been published online in the Journal of Neuroscience Research (http://dx.doi.org/10.1002/jnr.24782). In this publication, Cognition scientists identify the sigma-2 (-2) receptor as integral in the pathology of Parkinsons disease.

In Parkinsons disease, cumulative damage from a variety of stressors results in structural changes in the -synuclein protein. Aggregates of -synuclein are strongly correlated with disease pathology in Parkinsons and related synucleinopathies such as dementia with Lewy bodies and multiple system atrophy. In these diseases, -synuclein oligomers have been shown to disrupt several important cellular functions including autophagy and intracellular trafficking. When these processes are impaired, aggregated -synuclein and other altered proteins build up in neurons, causing further damage and eventual cell death.

Cognition scientists conducted extensive screening to identify compounds that rescue neurons from -synuclein oligomer-induced deficits, specifically in autophagy and trafficking processes. The compounds that had the most profound effects were discovered to be -2 receptor antagonists. This is consistent with findings reported in the literature describing -2 receptor components, TMEM97 and PGRMC1, as regulators of these pathways, but it is the first time that -2 antagonists have been demonstrated to have effects against -synuclein oligomers.

These data support the hypothesis that -2 receptor antagonists could represent a unique therapeutic approach to treating some of the underlying disease pathology in Parkinsons disease and potentially other related diseases like dementia with Lewy bodies, explained Susan Catalano, Ph.D., Cognitions founder and chief science officer. We have plans to explore one or more compounds from our library of -2 receptor antagonists in models of Parkinsons disease to better understand the role of -2 receptors in synucleinopathies.

About Cognition Therapeutics, Inc.Cognition Therapeutics, Inc. has discovered and is developing a pipeline of novel, disease modifying, oral drug candidates to treat a broad array of neurodegenerative and neuro-ophthalmic disorders. Our pipeline compounds uniquely target the -2 receptor, a key regulator of the cellular damage response. CT1812, our lead product candidate, is being assessed in a comprehensive clinical program for Alzheimers disease, including a 540-person Phase 2 study in collaboration with ACTC and supported by a competitive grant from the National Institute on Aging. Additional information about Cognition and its product candidates may be found online at http://www.cogrx.com.

Cautionary Statement Regarding Forward Looking Statements This press release contains forward-looking statement, including those concerning the development and commercialization of Cognition Therapeutics product candidates and pipeline, their potential benefits and the Companys expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future results to differ materially from such statements. These statements are based on information that is available as of date of this press release, and except as required by law, we undertake no obligation to update any such statements.

This press release contains references to CT1812, an investigational product. Use of CT1812 has not been approved by the FDA.

See original here:
Cognition Therapeutics Publishes Evidence Identifying Receptor Integral in Parkinson's Disease Pathology - GlobeNewswire

University of Maryland Launches New Brain and Behavior Institute, Announces Founding Director – Yahoo Finance

The University of Maryland launched the Brain and Behavior Institute to elevate the university's research and teaching programs in neuroscience and promote innovative, multidisciplinary approaches to solve the most pressing problems of nervous system function and disease.

COLLEGE PARK, Md., Jan. 27, 2021 /PRNewswire-PRWeb/ -- University of Maryland Senior Vice President and Provost Mary Ann Rankin announced last week the establishment of the new Brain and Behavior Institute (BBI) and appointed its founding director, UMD Biology Professor Elizabeth Quinlan.

The BBI will elevate the university's research and teaching programs in neuroscience and promote innovative, multidisciplinary approaches to solve the most pressing problems of nervous system function and disease. A primary goal of the institute is to strengthen collaborations among neuroscientists, engineers, computer scientists, mathematicians, physical scientists, cognitive scientists and humanities scholars.

"Understanding the brain and how it influences behavior is one of the most important and complicated grand challenges of our time, and our success ultimately depends on teamwork," said Amitabh Varshney, dean of UMD's College of Computer, Mathematical, and Natural Sciences (CMNS). "By establishing this new institute and appointing a strong leader who has experience with interdisciplinary research, our BBI faculty members will be able to build on their strengths and work together across their diverse fields, lending expertise and support to each other's efforts, and take our university's high-quality neuroscience research program to the next level."

For the past five years, UMD invested in the Brain and Behavior Initiative to foster interdisciplinary interactions in neuroscience across its College Park campus, and the provost's announcement of the new institute renews and expands the university's commitment to neuroscience research and teaching. At the heart of the initiative was a desire for a collaborative research community across the physical and life sciences. The initiative's seed grant program yielded a 900% return on seed grant investments, through 15 awards from private organizations and government funding, including the National Institutes of Health (NIH) BRAIN Initiative, National Institute of Mental Health, National Science Foundation, and Air Force Office of Scientific Research.

Story continues

The institute will play a vital role in the university's neuroscience ecosystem, which also includes the Neuroscience and Cognitive Science interdisciplinary graduate program and new undergraduate neuroscience major launched last fall. The BBI will also continue to strengthen interactions with collaborators at other institutions, including the University of Maryland, Baltimore (UMB).

A campus-wide endeavor, the BBI is administratively housed in CMNS and supported financially by the Office of the Provost, UM Center for Economic and Entrepreneurship Development, A. James & Alice B. Clark Foundation, Division of Research, CMNS, A. James Clark School of Engineering, College of Behavioral and Social Sciences, School of Public Health, College of Education, and College of Arts and Humanities.

"The BBI will recruit outstanding faculty, tools, and partnerships to expand and elevate interdisciplinary research and training in neuroscience," Quinlan said. "By strengthening and diversifying interactions between neuroscience and complementary disciplines, the BBI is positioning UMD to be a world leader in advancing innovations in experimental and analytical approaches to understanding the brain and behavior."

As the institute director, Quinlan will hold the Clark Leadership Chair in Neuroscience, which was endowed with a gift from the A. James & Alice B. Clark Foundation that was matched by the state's Maryland E-Nnovation Initiative Fund. Quinlan also has a joint appointment in the Department of Anatomy and Neurobiology at UMB.

In her own research program, Quinlan's research has identified changes in the brain that occur with aging and pioneered strategies to promote recovery of functions lost with age. The research in her lab has been continuously funded by the NIH since 2002.

Quinlan served as co-director of the Brain and Behavior Initiative and the MPowering the State initiative on Brain Health and Human Performance from 2018 to 2020. In the latter role, she strengthened collaborative neuroscience research and graduate education between UMD and the University of Maryland School of Medicine. From 2007 to 2016, she directed the physiological systems concentration area of the Biological Sciences Graduate Program.

She joined UMD in 2001 as an assistant professor, following postdoctoral fellowships at Brown University and the University of Virginia. Quinlan earned a Ph.D. in biological sciences from the University of Illinois at Chicago and a B.S. in psychology/biology from the University of Iowa.

"She incorporates a highly interdisciplinary approach to neuroscience in both classroom and lab settings," Rankin said of Quinlan in her announcement. "I have no doubt that she will advance the rising profile of Maryland neuroscience research and promote the success of the BBI community."

Media Contact

Abby Robinson, UMD, 301-405-5845, abbyr@umd.edu

SOURCE University Of Maryland

Originally published January 27, 2021, 1:35 PM

Read the original post:
University of Maryland Launches New Brain and Behavior Institute, Announces Founding Director - Yahoo Finance

This Is Where Empathy Lives in the Brain, and How It Works – Singularity Hub

Mind reading comes easily to most of us.

For all our divisions, humans are uncannily efficient at simulating another persons thoughts and beliefs. Its how you can walk a mile in someone elses shoes, know where theyre coming from, and in turn, generate empathy or predict how your actions impact others. Most of the time, we can even do this when we fundamentally disagree with the other persons point of view.

This mysterious ability to hop into someone elses headheck, even just to admit that theyre conscious beings with their own mindsis dubbed the theory of mind. Its simulation at its very best, where it allows us to connect and interact with others not just based on our own thoughts and actions, but also on our understanding of theirs. Its what lets you guess why your friend is upset on her birthday. Its behind strategy games like chess and entire disciplines such as game theory. Its what makes human society flourish or fail.

The problem? No one really knows how theory of mind works in our headsbut thats set to change.

This week, in a study with over half a dozen people, a team from Harvard Medical School and MIT recorded directly from single neurons in the forepart of their brains. For the first time, the scientists identified a special group of cells that lets us acknowledge and predict someone elses hidden beliefs. Even crazier, these neurons loyally encoded demonstrably false ideas that others may have, and beliefs that the person being studied doesnt necessarily agree with.

In other words, each of us has a smattering of brain cells dedicated to modeling another mind inside our own heads.

Until now, it wasnt clear whether or how neurons were able to perform these social cognitive computations, said study author Mohsen Jamali.

The results propelled a centuries-old debate on the nature of self and other into a new, scientifically-grounded era. But to lead author Dr. Ziv Williams, it also builds a framework to better capture the intricacies of how we model mindsand when or why it fails. Autism, for example, often leads to a breakdown in the ability to gauge social cues. People with brain injuries due to trauma can also lose that predictive superpower. And outside our own species, a model of how we model each others minds could form a powerful tool to bolster AI, providing them with an artificial theory of mind and a lot more common sense when dealing with people.

Debates over the theory of mind have roots going back to 17th-century philosophy. But modern excitement, especially in neuroscience, sparked in the early 1990s, when neuroscientists captured the inner electrical dialogue of a very special type of neurons.

Recording from the motor regions of the brains of macaque monkeys, they found a bizarre population that fired not only when the monkey waved its arm aroundsay, to grab an apple or ring a bellbut also when it watched another monkey perform the same action. Even weirder, the same neurons sparked with electrical activity when the monkey heard someone else performing the task in another room. Unlike any other known type of brain cell at the time, these mirror neurons seemed to encode for another beings actions and goals, rather than those of its own host.

Mirror neurons exploded in popularity for the next few decades. Some believed theyre the seat of empathy. Others thought theyre central to human social interaction capabilities, such as speech. One prominent pop-culture neuroscientist even went as far as saying that these cells shaped our civilization.

Yet as more sophisticated tools and techniques grew in social neuroscience, people soon realized that mirror neurons werent the end-all of empathy, language, or autism. Rather, using state-of-the-art brain imaging, scientists began honing down towards the front of the brain, sitting right behind the foreheadthe prefrontal cortexas the piece of the brain that captures anothers beliefs and thoughts.

Schooled by overpromises from mirror neurons, however, few were willing to hallmark the brain region as a supporter of theory of mind. After all, brain imaging captures the aggregated and averaged activity of thousands, if not more, neurons simultaneously. The readout is then influenced by other brain regions, painting a murky picture.

One way to sharpen it? Record from single neurons.

The new study blew people away with just that. Rather than relying on social but non-human animals, they went straight to the source: human volunteers who have electrodes implanted. These participants had already gone through brain surgery in preparation for a treatment for Parkinsons disease, and bravely signed on for the study. This allowed the team to directly record from single neurons in human brainssomething generally outside the reach of most theory of mind studies.

In all, they tapped into over 320 neurons embedded in the subjects frontal brains. As the implanted microelectrodes silently recorded the brain cells electrical activity, the team asked the participants to listen to a short story.

Take this scenario: You and Tom see a jar on the table. After Tom leaves, you move the jar to the cupboard. The listener knows that the jar is in the cupboard. But Tom doesnt. Because of theory of mind, we can reason that Tom will still think the jar is on the table.

The team then asked the listeners two seemingly simple questions. The first was where is the jar, or an objective assessment based on the listeners understanding. The second was more interestingwhere does Tom think the jar is? which probes the brains simulation of Toms mind.

Immediately, the team found a slew of neurons that surprisingly captured the distinction between internal beliefs and those of others. About 20 percent of recorded neurons reliably fired with activity when they predicted Toms belief. An even higher percentage sparked to life when Tom stated a true beliefthat is, true from his perspective. In all, the electrical activity of these neurons could predict nearly 80 percent of the time whether the listener accurately predicted Toms mental image of the jar.

To rephrase: we have neurons in our heads that encode for someone elses idea of reality, rather than whats actually true or real. This holds rather unnerving implications, in that the neurons solely reflect someone elses specific perspectiveyour perspective, or the truth, doesnt come into play.

If youre thinking oh well, these brain cells just respond to prediction, the authors have answers here too. It gets weirder.

For one, the cells that encode data for Toms ideas update to his perception of reality. When the participants heard that after Tom leaves, you move the jar to the cupboard as he watches you through the window, the same cells that encoded Toms perspective will shift gears, leading to the answer that now Tom knows the jar is in the cupboard. Your brain cells, encoding for someone elses beliefs, will update when their beliefsnot your ownupdate.

For another, the neurons also captured specific details about Toms beliefs. Using stories similar to the jar and cupboard, for example, the team found that these mind-reading neurons could encode for the items identity (a jar versus a table or vegetables), its location, color, and other characteristics. Compiling all the tests together, the team built a model with these neurons that could accurately predict another persons concept at nearly six times more than chance, regardless of the difficulty of reasoning.

Each neuron is encoding different bits of information, said Jamali. By combining the computations of all the neurons, you get a very detailed representation of the contents of anothers beliefs and an accurate prediction of whether they are true or false.

Are these predictive neurons just another mirror neuron story in the making? Many dont think so. Dr. Uta Frith, an Emeritus Professor at UCL Institute of Cognitive Neuroscience, commented, Amazing that single cells in [the prefrontal cortex]show activity during mentalizing, recapitulating findings from more blunt human brain recording instruments such as MRI. But mostly, the leap is in our methods for probing our own mindseven as they encode for someone elses. Its amazing that this type of recording can be done at all, said Frith.

Image Credit: Gerd Altmann from Pixabay

Read the original:
This Is Where Empathy Lives in the Brain, and How It Works - Singularity Hub

Cognito Therapeutics Appoints Mark Day, Ph.D., as Chief Business Officer – Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage company leading the development of a new class of disease-modifying digital therapeutics to treat neurodegenerative disorders including Alzheimers disease, announced today the appointment of Mark Day, Ph.D., as Chief Business Officer. In this role, Dr. Day will drive business development and partnership activities at Cognito in conjunction with the Cognito leadership team.

Dr. Day brings more than 21 years of business, corporate, research and development strategy expertise to Cognito. He has evaluated over 300 programs, resulting in a uniquely broad knowledge base and network in the pharmaceutical industry. He has successfully led product licensing, strategic alliances, mergers and acquisitions and product development programs with major pharmaceutical and biotechnology companies in neuroscience and rare disease indications.

Prior to joining Cognito, Dr. Day was Vice President, head of the McQuade Centre for Research and Development & Early-Stage Life Science Investment (MSRD) at Otsuka U.S., where he evaluated numerous early-stage central nervous system (CNS) programs. Prior to Otsuka, he was the Chief Executive Officer at Bioasis Technologies, Inc., a biopharmaceutical company developing novel therapies for CNS disorders. He has also held senior roles at Alexion Pharmaceuticals, Wyeth and Abbott.

As Cognito continues to build momentum following our recent FDA Breakthrough Device Designation for our lead product for the treatment of Alzheimers, we are excited to have Mark join us to further strengthen our leadership team, said Brent Vaughan, Chief Executive Officer of Cognito Therapeutics. His depth of knowledge leading therapeutic programs in neuroscience and CNS disorders will be invaluable, as we expand the development of Cognitos pipeline of digital therapeutics to effect disease modification in a broader range of neurodegenerative diseases.

Cognitos digital therapeutic device has the potential to transform the treatment landscape across a number of indications by addressing the etiology of neurodegenerative diseases, beginning with Alzheimers, said Mark Day, Ph.D., Chief Business Officer, Cognito Therapeutics. I look forward to working with Brent and the rest of the executive leadership team while leveraging pharmaceutical and biotech development efforts to bring Cognitos next-generation digital therapeutic devices to patients suffering from neurodegenerative disorders and other chronic diseases.

Dr. Day earned a B.Sc. (Hons) in Biological Psychology and a Ph.D. in Neuroscience from Cardiff University. He completed his post doctorate studies in systems level neuroscience at The University of Edinburgh. Dr. Day has authored more than 100 peer-reviewed scientific papers in leading medical journals on translational medicine, impulsivity, stroke, cognitive dysfunction in neurological and psychiatric illness such as Alzheimers disease and ADHD, including first authorships in Nature, Science, Nature Neuroscience, Neuroimaging and Proceedings of the Royal Society.

About Cognito Therapeutics

Cognito Therapeutics is a clinical-stage company developing a pipeline of disease-modifying digital therapeutics that have shown drug-like effects to treat neurodegenerative disorders including Alzheimers disease. The companys licensed proprietary neuromodulation platform technology, developed by scientific founders at MIT, Professors Li-Huei Tsai and Ed Boyden is a non-invasive, neurostimulation therapy utilizing visual and auditory stimulation to treat neurodegenerative diseases. The company is based in Boston and San Francisco. For more information, please visit http://www.cognitotx.com. Follow us on Twitter at @cognitotx.

See the rest here:
Cognito Therapeutics Appoints Mark Day, Ph.D., as Chief Business Officer - Business Wire

Assistant Professor in Cognitive Neuroscience, PSYC21-52 job with DURHAM UNIVERSITY | 243068 – Times Higher Education (THE)

The Department of Psychology at Durham University seeks to appoint talented individuals to the role of Assistant Professor. In the current call, we welcome applications from those with research and teaching interests in the broad field of Cognitive Neuroscience. This post offers an exciting opportunity to make a major contribution to the development of internationally excellent research and teaching while allowing you unrivalled opportunities to progress and embed your career in an exciting and progressive institution. For more information, please visit our Department pages at https://www.dur.ac.uk/psychology/

The Cognitive Neuroscience group benefits from cutting-edge cognitive neuroscience research facilities including a 3T fMRI scanner (and a 0T mock scanner for piloting and training purposes), excellent facilities for rodent behavioural neuroscience, neurostimulation facilities, EEG, state of the art mobile and lab-based eye tracking, whole body motion capture, immersive virtual reality, a molecular diagnostics lab, sound attenuated rooms, a fully equipped molecular diagnostics laboratory, patient testing facilities and access to high-performance computing facilities. The group leads on impact and engagement around blindness, stroke and dementia with strong links to the NHS and clinically relevant populations. For more information about our research visit https://www.dur.ac.uk/psychology/research/groups/cognitive/.

The Department of Psychology is an internationally recognised centre of research excellence and interdisciplinarity across the breadth of psychological and behavioural science. We are currently ranked in the top 100 of Psychology Departments world-wide according to the QS World Rankings. The department's research groupings reflect our major areas of activity: Cognitive Neuroscience, Developmental Science, & Quantitative Social Psychology. Each group also leads a taught Masters programme, alongside a prestigious undergraduate programme in Psychology and a new undergraduate programme in Behavioural Science, extending our research strengths into the next generation. In addition, the department houses a number of University Research Centres which bring in staff from across the department, university, and region to focus on key research issues. The department's broad approach to the discipline places it in an excellent position to take advantage of emerging opportunities and challenges and our collegiate approach allows staff to work across research areas to provide novel solutions to global problems.

Durham University is one of the world's top universities with strengths across the Arts and Humanities, Sciences and Social Sciences. The University sits in a beautiful historic city where it shares ownership of a UNESCO World Heritage Site with Durham Cathedral. A collegiate University, Durham recruits outstanding students from across the world and offers an unmatched wider student experience. Less than 3 hours north of London, an hour and a half south of Edinburgh, and ten minutes from the centre of Newcastle, County Durham is a region steeped in history and natural beauty. Close to the Northumberland National park and coastline, the Durham Dales, including the North Pennines Area of Outstanding Natural Beauty, our University is situated within truly breath-taking scenery and local attractions.

More:
Assistant Professor in Cognitive Neuroscience, PSYC21-52 job with DURHAM UNIVERSITY | 243068 - Times Higher Education (THE)

University of Maryland Launches New Brain and Behavior Institute, Announces Founding Director – PR Web

Elizabeth Quinlan, Biology Professor at the University of Maryland

COLLEGE PARK, Md. (PRWEB) January 27, 2021

University of Maryland Senior Vice President and Provost Mary Ann Rankin announced last week the establishment of the new Brain and Behavior Institute (BBI) and appointed its founding director, UMD Biology Professor Elizabeth Quinlan.

The BBI will elevate the universitys research and teaching programs in neuroscience and promote innovative, multidisciplinary approaches to solve the most pressing problems of nervous system function and disease. A primary goal of the institute is to strengthen collaborations among neuroscientists, engineers, computer scientists, mathematicians, physical scientists, cognitive scientists and humanities scholars.

"Understanding the brain and how it influences behavior is one of the most important and complicated grand challenges of our time, and our success ultimately depends on teamwork, said Amitabh Varshney, dean of UMDs College of Computer, Mathematical, and Natural Sciences (CMNS). "By establishing this new institute and appointing a strong leader who has experience with interdisciplinary research, our BBI faculty members will be able to build on their strengths and work together across their diverse fields, lending expertise and support to each others efforts, and take our university's high-quality neuroscience research program to the next level."

For the past five years, UMD invested in the Brain and Behavior Initiative to foster interdisciplinary interactions in neuroscience across its College Park campus, and the provosts announcement of the new institute renews and expands the universitys commitment to neuroscience research and teaching. At the heart of the initiative was a desire for a collaborative research community across the physical and life sciences. The initiatives seed grant program yielded a 900% return on seed grant investments, through 15 awards from private organizations and government funding, including the National Institutes of Health (NIH) BRAIN Initiative, National Institute of Mental Health, National Science Foundation, and Air Force Office of Scientific Research.

The institute will play a vital role in the universitys neuroscience ecosystem, which also includes the Neuroscience and Cognitive Science interdisciplinary graduate program and new undergraduate neuroscience major launched last fall. The BBI will also continue to strengthen interactions with collaborators at other institutions, including the University of Maryland, Baltimore (UMB).

A campus-wide endeavor, the BBI is administratively housed in CMNS and supported financially by the Office of the Provost, UM Center for Economic and Entrepreneurship Development, A. James & Alice B. Clark Foundation, Division of Research, CMNS, A. James Clark School of Engineering, College of Behavioral and Social Sciences, School of Public Health, College of Education, and College of Arts and Humanities.

The BBI will recruit outstanding faculty, tools, and partnerships to expand and elevate interdisciplinary research and training in neuroscience, Quinlan said. By strengthening and diversifying interactions between neuroscience and complementary disciplines, the BBI is positioning UMD to be a world leader in advancing innovations in experimental and analytical approaches to understanding the brain and behavior.

As the institute director, Quinlan will hold the Clark Leadership Chair in Neuroscience, which was endowed with a gift from the A. James & Alice B. Clark Foundation that was matched by the states Maryland E-Nnovation Initiative Fund. Quinlan also has a joint appointment in the Department of Anatomy and Neurobiology at UMB.

In her own research program, Quinlan's research has identified changes in the brain that occur with aging and pioneered strategies to promote recovery of functions lost with age. The research in her lab has been continuously funded by the NIH since 2002.

Quinlan served as co-director of the Brain and Behavior Initiative and the MPowering the State initiative on Brain Health and Human Performance from 2018 to 2020. In the latter role, she strengthened collaborative neuroscience research and graduate education between UMD and the University of Maryland School of Medicine. From 2007 to 2016, she directed the physiological systems concentration area of the Biological Sciences Graduate Program.

She joined UMD in 2001 as an assistant professor, following postdoctoral fellowships at Brown University and the University of Virginia. Quinlan earned a Ph.D. in biological sciences from the University of Illinois at Chicago and a B.S. in psychology/biology from the University of Iowa.

She incorporates a highly interdisciplinary approach to neuroscience in both classroom and lab settings, Rankin said of Quinlan in her announcement. I have no doubt that she will advance the rising profile of Maryland neuroscience research and promote the success of the BBI community.

Share article on social media or email:

See the rest here:
University of Maryland Launches New Brain and Behavior Institute, Announces Founding Director - PR Web